Effect of neuroleptics on indoleamine-N-methyltransferase activity and brain metabolism of bufotenin.
D000818:Animals; D000928:Antidepressive Agents / Q000037:antagonists & inhibitors; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D002027:Bufotenin / Q000378:metabolism*; D008297:Male; D008780:Methyltransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011817:Rabbits; D012701:Serotonin / Q000031:analogs & derivatives*; D014363:Tryptamines / Q000037:antagonists & inhibitors / Q000378:metabolism
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D014363:Tryptamines; D002027:Bufotenin; D012701:Serotonin; D008780:Methyltransferases; C021438:indoleamine-N-methyltransferase